Skip to main content

Peer Review reports

From: A phase II clinical trial of 6-mercaptopurine (6MP) and methotrexate in patients with BRCA defective tumours: a study protocol

Original Submission
28 Oct 2014 Submitted Original manuscript
8 Dec 2014 Author responded Author comments - Corran Roberts
Resubmission - Version 2
8 Dec 2014 Submitted Manuscript version 2
11 Dec 2014 Editorially accepted
19 Dec 2014 Article published 10.1186/1471-2407-14-983

You can find further information about peer review here.

Back to article page